By John Gever, Senior Editor Military doctors can use a portable polymerase chain reaction (PCR) testing device to diagnose novel H1N1 flu infections in troops overseas, the FDA announced. The emergency authorization was approved "to better protect our troops," said FDA Commissioner Margaret A. Hamburg, MD, in a statement. The device, called JBAIDS (Joint Biological Agent Identification and Diagnostic System), is a rugged, suitcase-sized instrument that can run PCR-based molecular diagnostic tests. It has been under development for several years by a consortium of military health research centers, the CDC, and academic medical laboratories. The development program began in the...